Literature DB >> 22732465

TB diagnostic capacity in sub-Saharan African HIV care settings.

Suzue Saito1, Andrea A Howard, Michael J A Reid, Batya Elul, Anna Scardigli, Sabine Verkuijl, Alaine U Nyaruhirira, Denis Nash.   

Abstract

As HIV care services continue to scale-up in sub-Saharan Africa, adequate tuberculosis diagnostic capacity is vital to reduce mortality among HIV-infected persons. A structured survey was administered at 663 health facilities providing HIV care to 908,043 patients in across 9 sub-Saharan African countries to estimate the proportion of facilities and HIV patients at these facilities with access TB-related diagnostic tests. Sputum smear microscopy was available at 87% of facilities (representing 97% of patients), chest x-ray at 26% of facilities (representing 56% of patients), tuberculin skin tests were available at 12% of facilities (representing 33% of patients). Acid-fast bacillus culture was available on-/off-site at 53% of facilities (representing 77% of patients). Primary health facilities had lower availability of tuberculosis diagnostic tests compared with secondary and tertiary health facilities. As HIV care continues to decentralize to primary health facilities, a corresponding expansion of diagnostic capacity to lower levels of the health system will be essential.

Entities:  

Mesh:

Year:  2012        PMID: 22732465      PMCID: PMC3890234          DOI: 10.1097/QAI.0b013e3182638ec7

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  9 in total

1.  Evaluation of the analytical performance of the Xpert MTB/RIF assay.

Authors:  Robert Blakemore; Elizabeth Story; Danica Helb; JoAnn Kop; Padmapriya Banada; Michelle R Owens; Soumitesh Chakravorty; Martin Jones; David Alland
Journal:  J Clin Microbiol       Date:  2010-05-26       Impact factor: 5.948

2.  Xpert® MTB/RIF for national tuberculosis programmes in low-income countries: when, where and how?

Authors:  A Trébucq; D A Enarson; C Y Chiang; A Van Deun; A D Harries; F Boillot; A Detjen; P I Fujiwara; S M Graham; I Monedero; I D Rusen; H L Rieder
Journal:  Int J Tuberc Lung Dis       Date:  2011-10-13       Impact factor: 2.373

Review 3.  Multidrug and extensively drug-resistant TB (M/XDR-TB): problems and solutions.

Authors:  Rajendra Prasad
Journal:  Indian J Tuberc       Date:  2010-10

Review 4.  Diagnosis of smear-negative pulmonary tuberculosis in people with HIV infection or AIDS in resource-constrained settings: informing urgent policy changes.

Authors:  Haileyesus Getahun; Mark Harrington; Rick O'Brien; Paul Nunn
Journal:  Lancet       Date:  2007-06-16       Impact factor: 79.321

Review 5.  New approaches and emerging technologies in the diagnosis of childhood tuberculosis.

Authors:  Ben J Marais; Madhukar Pai
Journal:  Paediatr Respir Rev       Date:  2007-06-05       Impact factor: 2.726

Review 6.  Treatment of latent tuberculosis infection in HIV infected persons.

Authors:  Christopher Akolo; Ifedayo Adetifa; Sasha Shepperd; Jimmy Volmink
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

7.  Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology.

Authors:  Danica Helb; Martin Jones; Elizabeth Story; Catharina Boehme; Ellen Wallace; Ken Ho; JoAnn Kop; Michelle R Owens; Richard Rodgers; Padmapriya Banada; Hassan Safi; Robert Blakemore; N T Ngoc Lan; Edward C Jones-López; Michael Levi; Michele Burday; Irene Ayakaka; Roy D Mugerwa; Bill McMillan; Emily Winn-Deen; Lee Christel; Peter Dailey; Mark D Perkins; David H Persing; David Alland
Journal:  J Clin Microbiol       Date:  2009-10-28       Impact factor: 5.948

Review 8.  Facing the crisis: improving the diagnosis of tuberculosis in the HIV era.

Authors:  Mark D Perkins; Jane Cunningham
Journal:  J Infect Dis       Date:  2007-08-15       Impact factor: 5.226

9.  Approaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings.

Authors:  Michael J A Reid; N Sarita Shah
Journal:  Lancet Infect Dis       Date:  2009-03       Impact factor: 25.071

  9 in total
  18 in total

1.  One-stop TB-HIV services evaluation in Rwanda: comparison of the 2001-2005 and 2006-2010 cohorts.

Authors:  A Ndagijimana; E Rugigana; C B Uwizeye; J Ntaganira
Journal:  Public Health Action       Date:  2015-12-21

2.  Symptom screening for active tuberculosis in pregnant women living with HIV.

Authors:  Sylvia M LaCourse; Lisa M Cranmer; Adrie Bekker; Karen R Steingart; Danae Black; David J Horne; Eyal Oren; Sherri Pals; Surbhi Modi; Jyoti Mathad
Journal:  Cochrane Database Syst Rev       Date:  2018-01-24

3.  Diagnostic accuracy and clinical role of rapid C-reactive protein testing in HIV-infected individuals with presumed tuberculosis in South Africa.

Authors:  P K Drain; L Mayeza; P Bartman; R Hurtado; P Moodley; S Varghese; G Maartens; G G Alvarez; D Wilson
Journal:  Int J Tuberc Lung Dis       Date:  2014-01       Impact factor: 2.373

4.  Diagnostic delays and clinical decision making with centralized Xpert MTB/RIF testing in Durban, South Africa.

Authors:  Gabriel M Cohen; Paul K Drain; Farzad Noubary; Christie Cloete; Ingrid V Bassett
Journal:  J Acquir Immune Defic Syndr       Date:  2014-11-01       Impact factor: 3.731

5.  Value of urine lipoarabinomannan grade and second test for optimizing clinic-based screening for HIV-associated pulmonary tuberculosis.

Authors:  Paul K Drain; Elena Losina; Sharon M Coleman; Janet Giddy; Douglas Ross; Jeffrey N Katz; Ingrid V Bassett
Journal:  J Acquir Immune Defic Syndr       Date:  2015-03-01       Impact factor: 3.731

6.  Causes and outcome of hospitalization among HIV-infected adults receiving antiretroviral therapy in Mulago hospital, Uganda.

Authors:  A M N Namutebi; M R K Kamya; P Byakika-Kibwika
Journal:  Afr Health Sci       Date:  2013-12       Impact factor: 0.927

7.  Intensified tuberculosis case finding among HIV-infected persons using a WHO symptom screen and Xpert(®) MTB/RIF.

Authors:  M W Adelman; M Tsegaye; R R Kempker; T Alebachew; K Haile; A Tesfaye; A Aseffa; H M Blumberg
Journal:  Int J Tuberc Lung Dis       Date:  2015-10       Impact factor: 2.373

8.  Tuberculosis in antiretroviral treatment programs in lower income countries: availability and use of diagnostics and screening.

Authors:  Lukas Fenner; Marie Ballif; Claire Graber; Venerandah Nhandu; Jean Claude Dusingize; Claudia P Cortes; Gabriela Carriquiry; Kathryn Anastos; Daniela Garone; Eefje Jong; Joachim Charles Gnokoro; Omar Sued; Samuel Ajayi; Lameck Diero; Kara Wools-Kaloustian; Sasisopin Kiertiburanakul; Barbara Castelnuovo; Charlotte Lewden; Nicolas Durier; Timothy R Sterling; Matthias Egger
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

9.  Reviewing progress: 7 year trends in characteristics of adults and children enrolled at HIV care and treatment clinics in the United Republic of Tanzania.

Authors:  Harriet Nuwagaba-Biribonwoha; Bonita Kilama; Gretchen Antelman; Ahmed Khatib; Annette Almeida; William Reidy; Gongo Ramadhani; Matthew R Lamb; Redempta Mbatia; Elaine J Abrams
Journal:  BMC Public Health       Date:  2013-10-27       Impact factor: 3.295

10.  Diagnostic accuracy of a point-of-care urine test for tuberculosis screening among newly-diagnosed HIV-infected adults: a prospective, clinic-based study.

Authors:  Paul K Drain; Elena Losina; Sharon M Coleman; Janet Giddy; Douglas Ross; Jeffrey N Katz; Rochelle P Walensky; Kenneth A Freedberg; Ingrid V Bassett
Journal:  BMC Infect Dis       Date:  2014-02-26       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.